286 — Aidigong Maternal & Child Health Share Price
- HK$251.76m
- HK$962.81m
- HK$554.58m
Growth & Value
12m Forecast Rolling | Industry | Market | |
---|---|---|---|
PE Ratio (f) | n/a | ||
PEG Ratio (f) | n/a | ||
EPS Growth (f) | n/a | ||
Dividend Yield (f) | n/a |
Valuation (ttm) | Industry | Market | |
---|---|---|---|
Price to Book Value | 0.34 | ||
Price to Tang. Book | n/a | ||
Price to Free Cashflow | 7.38 | ||
Price to Sales | 0.48 | ||
EV to EBITDA | 75.16 |
Shareholder Activity
Type | Buy / Hold / Sell |
---|---|
Institutions | |
Directors | |
Community |
Guru Screens
Quality
Name | Industry | Market | |
---|---|---|---|
Return on Capital | -9.48% | ||
Return on Equity | -23.31% | ||
Operating Margin | -26.71% |
Financial Summary
Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
---|---|---|---|---|---|---|---|---|---|
Total Revenue | HK$m | 610.61 | 601.21 | 642.57 | 679.95 | 554.58 | 1,514.23 | n/a | 8.02% |
Operating Profit | m | ||||||||
Net Profit | m | ||||||||
EPS Reported | |||||||||
Diluted Normalised EPS | |||||||||
EPS Growth | % | +7901.45 | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
PE Ratio | x | ||||||||
PEG | |||||||||
Profitability | |||||||||
Operating Margin | % | ||||||||
ROA | % | ||||||||
ROCE | % | ||||||||
ROE | % | ||||||||
Cashflow | |||||||||
Op. Cashflow ps | |||||||||
Capex ps | |||||||||
Free Cashflow ps | |||||||||
Dividends | |||||||||
Dividend ps | |||||||||
Dividend Growth | % | ||||||||
Dividend Yield | % | ||||||||
Dividend Cover | x | ||||||||
Balance Sheet | |||||||||
Cash etc | m | ||||||||
Working Capital | m | ||||||||
NFA | m | ||||||||
Net Debt | m | ||||||||
Book Value | m | ||||||||
Diluted Weighted Average Shares | m | ||||||||
Book Value ps |
Other Ratios
Leverage (ttm) | Total | - Intang | + Pension |
---|---|---|---|
Gross Gearing | |||
Net Gearing | |||
Cash / Assets |
Liquidity (ttm) | |
---|---|
Curr. Ratio | |
Quick Ratio | |
Interest Cov. |
Efficiency (ttm) | |
---|---|
Asset Turnover | |
Recs Turnover | |
Stock Turnover |
Recent History
Latest interim period vs. prior period | Industry | Market | |
---|---|---|---|
Sales Growth | |||
EPS Growth |
3yr Compound Annual Growth Rate | Industry | Market | |
---|---|---|---|
Sales CAGR | |||
EPS CAGR | |||
DPS CAGR |
Profile Summary
Aidigong Maternal & Child Health Limited, formerly Common Splendor International Health Industry Group Limited, is a Hong Kong-based investment holding company principally engaged in health-related businesses. The Company operates through two segments. The Health Industry segment is engaged in the natural health food, medical anti-aging and health preservation base, medical and healthcare industry investment management business. The Investment and Finance segment is engaged in the investment and financing.
Directors
- Yufei Zhu CHM (58)
- King Ho Lam CTR
- Wai Kuen Cheung EDR (47)
- Runping Li EDR (38)
- Jiang Lin EDR (55)
- Wing Cheung Wong SEC (37)
- Kin Man Wong NED (68)
- Zhibo Yang NED (34)
- Chi Wing Lam NID (40)
- Yiu Kit Wong NID (53)
- Lin Yu NID (57)
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- June 11th, 1990
- Public Since
- September 7th, 1990
- No. of Employees
- 1,338
- Sector
- Healthcare Providers & Services
- Industry
- Healthcare
- Exchange
Stock Exchange of Hong Kong Limited
- Shares in Issue
- 192,183,832

- Address
- Room 2709-10, 27th Floor, North Tower,
- Web
- http://www.adg00286.hk/
- Phone
- +852 null26206623
- Auditors
- HLB Hodgson Impey Cheng
Upcoming Events for 286
Half Year 2025 Aidigong Maternal & Child Health Ltd Earnings Release
Similar to 286
Adicon Holdings
Stock Exchange of Hong Kong Limited
Arrail
Stock Exchange of Hong Kong Limited
Suzhou Basecare Medical
Stock Exchange of Hong Kong Limited
Beijing Health (Holdings)
Stock Exchange of Hong Kong Limited
Chaoju Eye Care Holdings
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:08 UTC, shares in Aidigong Maternal & Child Health are trading at HK$1.31. This share price information is delayed by 15 minutes.
Shares in Aidigong Maternal & Child Health last closed at HK$1.31 and the price had moved by -54.12% over the past 365 days. In terms of relative price strength the Aidigong Maternal & Child Health share price has underperformed the FTSE Developed Asia Pacific Index by -53.6% over the past year.
The overall consensus recommendation for Aidigong Maternal & Child Health is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAidigong Maternal & Child Health does not currently pay a dividend.
Aidigong Maternal & Child Health does not currently pay a dividend.
Aidigong Maternal & Child Health does not currently pay a dividend.
To buy shares in Aidigong Maternal & Child Health you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$1.31, shares in Aidigong Maternal & Child Health had a market capitalisation of HK$251.76m.
Here are the trading details for Aidigong Maternal & Child Health:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 286
Based on an overall assessment of its quality, value and momentum Aidigong Maternal & Child Health is currently classified as a . The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Aidigong Maternal & Child Health is HK$15.25. That is 1064.35% above the last closing price of HK$1.31.
Analysts covering Aidigong Maternal & Child Health currently have a consensus Earnings Per Share (EPS) forecast of HK$0.03 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Aidigong Maternal & Child Health. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -23.98%.
As of the last closing price of HK$1.31, shares in Aidigong Maternal & Child Health were trading matched their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Aidigong Maternal & Child Health PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at HK$1.31.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Aidigong Maternal & Child Health's management team is headed by:
- Yufei Zhu - CHM
- King Ho Lam - CTR
- Wai Kuen Cheung - EDR
- Runping Li - EDR
- Jiang Lin - EDR
- Wing Cheung Wong - SEC
- Kin Man Wong - NED
- Zhibo Yang - NED
- Chi Wing Lam - NID
- Yiu Kit Wong - NID
- Lin Yu - NID